Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores.

Childress ES, Wieting JM, Felts AS, Breiner MM, Long MF, Luscombe VB, Rodriguez AL, Cho HP, Blobaum AL, Niswender CM, Emmitte KA, Conn PJ, Lindsley CW
J Med Chem. 2019 62 (1): 378-384

PMID: 30350962 · DOI:10.1021/acs.jmedchem.8b01266

A scaffold hopping exercise from a monocyclic mGlu NAM with poor rodent PK led to two novel heterobicyclic series of mGlu NAMs based on either a functionalized pyrazolo[1,5- a]pyrimidine-5-carboxamide core or a thieno[3,2- b]pyridine-5-carboxamide core. These novel analogues possess enhanced rodent PK, while also maintaining good mGlu NAM potency, selectivity (versus mGlu and the remaining six mGlu receptors), and high CNS penetration. Interestingly, SAR was divergent between the new 5,6-heterobicyclic systems.

MeSH Terms (15)

Allosteric Regulation Amides Animals Central Nervous System Drug Evaluation, Preclinical Half-Life Humans Inhibitory Concentration 50 Protein Isoforms Pyrazoles Pyridines Pyrimidines Rats Receptors, Metabotropic Glutamate Structure-Activity Relationship

Connections (1)

This publication is referenced by other Labnodes entities: